Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
15
Recruiting, any sponsor type, condition "ankylosing spondylitis"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed182
15 trials
Showing 1 to 15, recently updated first.
- A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing SpondylitisPivotal-lookingRecruiting
Lynk Pharmaceuticals Co., LtdIndustry
NCT07237568 · 352 participants (planned) · Start Aug 29, 2025 · Primary completion Nov 2026
Drug: LNK01001; Placebo · For: Ankylosing Spondylitis
Sites: Beijing, China
Huabo Biopharm Co., Ltd.Industry
NCT07920861 · 90 participants (planned) · Start Jan 19, 2026 · Primary completion Dec 31, 2026
Drug: HB0017 Injection · For: Psoriasis; Ankylosing Spondylitis
Sites: Hangzhou, China
Mabsoft Therapeutics (Shanghai) Co., Ltd.Industry
NCT07903493 · 32 participants (planned) · Start Nov 30, 2026 · Primary completion Jul 30, 2027
Drug: MST-931; MST-931 Placebo · For: Ankylosing Spondylitis (AS)
Sites: Herston, Australia
NCT06668181 · 40 participants (planned) · Start Mar 11, 2025 · Primary completion Apr 12, 2028
Drug: Bimekizumab · For: Enthesitis-related Arthritis; Juvenile Psoriatic Arthritis
Sites: Calgary, Canada; Montreal, Canada; Saskatoon, Canada · 23 sites in all
Novartis PharmaceuticalsNovartis (NVS)
NCT06905288 · 70 participants (planned) · Start Apr 2, 2025 · Primary completion Dec 31, 2026
Drug: Secukinumab · For: Ankylosing Spondylitis
Sites: Jinju, South Korea; Busan, South Korea; Gwangju, South Korea
University Hospital of North NorwayAcademic, hospital or other
NCT06451588 · 99 participants (planned) · Start Jun 1, 2024 · Primary completion May 2027
Drug: FMT; Placebo · For: Axial Spondyloarthritis; Ankylosing Spondylitis; Dysbiosis and 6 more
Sites: Tromsø, Norway
NYU Langone HealthAcademic, hospital or other
NCT07138898 · 80 participants (planned) · Start Dec 12, 2025 · Primary completion Jan 2028
Drug: Methotrexate; Sulfasalazine and 25 more · For: Rheumatic Disease
Sites: New York, New York
- A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing SpondylitisPivotal-lookingRecruiting
Tongji HospitalAcademic, hospital or other
NCT05303285 · 100 participants (planned) · Start Jun 14, 2024 · Primary completion Aug 31, 2026
Drug: Secukinumab 300mg s.c.; Secukinumab 150mg s.c. · For: Ankylosing Spondylitis (AS)
Sites: Wuhan, China · 3 sites in all
- Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.Pivotal-lookingRecruiting
Jiangsu vcare pharmaceutical technology co., LTDIndustry
NCT07172360 · 420 participants (planned) · Start Dec 26, 2025 · Primary completion Aug 30, 2027
Drug: VC005 tablets; VC005 Tablets Placebo · For: Active Ankylosing Spondylitis
Sites: Beijing, China
- A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)Pivotal-lookingRecruiting
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Industry
NCT07261644 · 500 participants (planned) · Start Nov 7, 2025 · Primary completion Jan 14, 2027
Drug: 608 dose; Placebo · For: Ankylosing Spondylitis
Sites: Beijing, China
- Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory DiseasesPivotal-lookingRecruiting
Odense University HospitalAcademic, hospital or other
NCT04924270 · 200 participants (planned) · Start Dec 13, 2023 · Primary completion Mar 1, 2027
Drug: Faecal microbiota transplantation · For: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis and 2 more
Sites: Odense, Denmark
- Effect and Safety of Benzathine Penicillin Combined With Etanercept on SpondyloarthritisPivotal-lookingRecruiting
Nanfang Hospital, Southern Medical UniversityAcademic, hospital or other
NCT06707194 · 340 participants (planned) · Start Jun 14, 2025 · Primary completion Mar 1, 2027
Drug: Etanercept; Benzathine Penicillin · For: Spondyloarthritis (SpA); Ankylosing Spondylitis (AS)
Sites: Hefei, China; Chongqing, China; Guangzhou, China · 6 sites in all
- A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and PlaceboPivotal-lookingRecruiting
Tasly Pharmaceutical Group Co., LtdIndustry
NCT06000956 · 408 participants (planned) · Start Sep 11, 2023 · Primary completion Dec 1, 2026
Drug: Jitongning tablets; a simulated agent of Jitongning tablets · For: Ankylosing Spondylitis
Sites: Beijing, China; Lanzhou, China; Shijiazhuang, China · 10 sites in all
Seoul National University HospitalAcademic, hospital or other
NCT01965132 · 10,000 participants (planned) · Start Dec 1, 2012 · Primary completion Dec 31, 2029
Drug: Biologic or targeted synthetic DMARD · For: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Sites: Seoul, South Korea
Region SkaneAcademic, hospital or other
NCT03839862 · 50 participants (planned) · Start Jan 1, 2019 · Primary completion Dec 31, 2025
Drug: TNF-inhibition · For: Spondyloarthropathies; Ankylosing Spondylitis
Sites: Lund, Sweden
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.